Takeda Pharmaceuticals

Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
Pharmaceutical Business Review
Takeda Pharmaceuticals
breakthrough status
FDA
pevonedistat
myelodysplastic syndrome
Flag link:
Lawmakers Seek Clarity From FDA on Recall of Lifesaving Drug
Lawmakers Seek Clarity From FDA on Recall of Lifesaving Drug
RAPS.org
Takeda Pharmaceuticals
hypoparathyroidism
Natpara
FDA
product recalls
Flag link:
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
CP Wire
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Flag link:
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Flag link:
Microbiome Report for Week Ending 10/27/18
Microbiome Report for Week Ending 10/27/18
CP Wire
Enterome
Takeda Pharmaceuticals
Microbiotica
microbiome
Flag link:
Microbiome Report for Week Ending 10/27/18
Enterome
Takeda Pharmaceuticals
Microbiotica
microbiome
Flag link:
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
Ninlaro
Takeda Pharmaceuticals
Multiple Myeloma
Flag link:
FTC Clears Takeda's Acquisition of Shire
Takeda Pharmaceuticals
Shire Pharmaceuticals
M&A
Flag link:
How Sanofi's setback could lead to better dengue vaccines
How Sanofi's setback could lead to better dengue vaccines
Reuters
Sanofi
dengue
vaccines
Dengvaxia
Takeda Pharmaceuticals
Flag link:
This antidepressant may be no better than cheaper alternatives. But demand could soon soar
This antidepressant may be no better than cheaper alternatives. But demand could soon soar
Stat
antidepressants
Lundbeck
Takeda Pharmaceuticals
Brintellix
Flag link: